Get email alerts when CUE insiders make a move — free, no credit card

CUE Insider Trading & Form 4 Activity

Cue Biopharma, Inc.
Last filing: Jul 15, 2026·1 day ago
NEUTRAL · LAST 90 DAYS
0%
buyers
$0
0 buys
$0
0 sells
$0
net buying
0
insiders
Tracking CUE insiders takes 3 seconds. Get free alerts →

Net flow — last 12 months

Monthly net of insider buys minus sells. Green months indicate net buying; red months indicate net selling.

Most active insiders

Ranked by total transaction value over the last 90 days.

INSIDERBOUGHTSOLDNET
Borie Dominique Christian
Chief Medical Officer
$0
Meluzio Michael Vincent
VP, Prin. Accounting Officer
$0
Meehan Viola Mong
Director
$0
Camardo Daniel A.
Director
$0
Lin Shao-Lee
Chief Executive Officer
$0
Garzone Pamela
Director
$0
Ray Sumita
Chief Legal Compliance Officer
$0
Sarraf Pasha
Director
$0

Recent transactions

Every Form 4 transaction for CUE, newest first.

AWARD
Borie Dominique Christian · Chief Medical Officer
Tx Jul 13·Filed Jul 15·EDGAR ↗
31,500 sh
AWARD
Meluzio Michael Vincent · VP, Prin. Accounting Officer
Tx Jul 9·Filed Jul 10·EDGAR ↗
40,942 sh
AWARD
Meehan Viola Mong · Director
Tx Jul 9·Filed Jul 10·EDGAR ↗
21,800 sh
AWARD
Camardo Daniel A. · Director
Tx Jul 9·Filed Jul 10·EDGAR ↗
21,800 sh
AWARD
Lin Shao-Lee · Chief Executive Officer
Tx Jul 9·Filed Jul 10·EDGAR ↗
327,537 sh
AWARD
Garzone Pamela · Director
Tx Jul 9·Filed Jul 10·EDGAR ↗
21,800 sh
AWARD
Ray Sumita · Chief Legal Compliance Officer
Tx Jul 9·Filed Jul 10·EDGAR ↗
54,589 sh
AWARD
Sarraf Pasha · Director
Tx Jul 9·Filed Jul 10·EDGAR ↗
21,800 sh
AWARD
Lin Shao-Lee · CHIEF EXECUTIVE OFFICER
Tx May 3·Filed May 7·EDGAR ↗
327,537 sh

Track every ticker you care about

Free plan includes 3 tickers, daily insider scans, and cluster alerts. No credit card.

Start free (3 tickers)See plans

Join investors tracking SEC filings.

About CUE insider trading data

Form 4 is the SEC filing required when an officer, director, or 10% owner of a public company buys or sells the company's stock. By law, these filings must be submitted within two business days of the trade. Tracenotes pulls every Form 4 filing for CUE from EDGAR, parses it, and surfaces the activity on this page.

What insider buying tells you. Open-market purchases by insiders are widely studied as a meaningful signal. Unlike stock awards (which are compensation, not conviction), an executive spending their own money to buy shares of the company they run is a vote of confidence. Studies have found insider-buying clusters — three or more insiders buying within a short window — outperform the broader market over the following year.

What insider selling tells you. Selling is noisier. Many sales are pre-scheduled under SEC Rule 10b5-1 plans, which let insiders sell on a fixed schedule regardless of company news. We label these "10b5-1" so you can see them. Discretionary sales — sales not tied to a plan — are more meaningful, especially when multiple insiders sell in quick succession.

Tracenotes methodology. We scan EDGAR daily for new Form 4 filings, parse them into individual transactions, and detect clusters when three or more distinct insiders buy or sell within a 14-day window. The data on this page covers the last 12 months. For deeper analysis, Tracenotes also runs language-change detection on 10-K and 10-Q filings — that's our core product.

See this for every ticker.

Tracenotes covers the S&P 500 and beyond. Pick any ticker — get the same depth of insider trading data.

AAPLNVDAMSFTTSLA

Free plan available — no credit card. Sign up free →

Frequently asked questions

What is a Form 4 filing?

Form 4 is the SEC disclosure required when a company insider — an officer, director, or 10% owner — buys or sells the company's stock. By law these filings must be submitted within two business days of the trade.

Is insider buying CUE always bullish?

Open-market purchases by insiders are widely viewed as a bullish signal because executives are spending their own money. Stock awards and option exercises are part of compensation and don't carry the same weight, which is why we treat them separately on this page.

What is a 10b5-1 trade?

A trade made under SEC Rule 10b5-1, which lets insiders pre-schedule sales weeks or months in advance. These sales execute on a fixed plan regardless of company news, so they're a weaker signal than discretionary sales. We label them with a "10b5-1" tag.

What is an insider cluster?

A cluster is when three or more distinct insiders buy or sell within a 14-day window. Clusters are studied as stronger signals than single trades because multiple people independently reach the same view. We surface active clusters on Cue Biopharma, Inc. (CUE) when they form.

Where does CUE insider trading data come from?

Every Form 4 filing for CUE is sourced directly from SEC EDGAR. Tracenotes scans EDGAR daily, parses each Form 4 into individual transactions, and updates this page within hours of new filings.

Nothing on this page constitutes investment advice. Form 4 data is sourced from SEC EDGAR and provided for research purposes only.

© 2026 Tracenotes · tracenotes.ai